Andrew Cothrel

Andrew Cothrel is an experienced entrepreneur and executive, currently serving as the President of Rushlight Ventures, LLC since July 2020, where leadership focuses on monetizing client intellectual property and enabling commercial success. In addition, Andrew co-founded Kilele Health in August 2021, acting as CEO and Director, overseeing innovations in wearable biosensor systems. Andrew holds board positions at Royal Biologics, Inc., Scioto Biosciences, Inc., and Amplified Sciences, Inc., contributing to advancements in healthcare and biotechnology. Previous roles include managing director at Blue Marble MedVentures and CEO of NovoSource, Inc., with a proven track record in fostering business growth and innovation in the medical field. Andrew's educational background includes degrees from The Ohio State University, University of Michigan, Cranfield School of Management, and London Business School.